Tranquille N, Emeis J J
Gaubius Laboratory IVVO-TNO, Leiden, The Netherlands.
Thromb Haemost. 1993 Mar 1;69(3):259-61.
The modulation of the induced acute release of tissue-type plasminogen activator (t-PA) and of von Willebrand factor (vWF) by compounds affecting cyclic nucleotide levels was studied, using an isolated rat hindleg perfusion system. Platelet-activating factor (PAF; 5 nM) or bradykinin (0.8 microM) were used to induce release of t-PA and vWF. The guanylate cyclase activators sodium nitroprusside and atrial natriuretic factor reduced the induced release of t-PA and vWF. Release was not affected by inhibiting nitric oxide production with NG-nitro-L-arginine. The effects of nitroprusside and atrial natriuretic factor could not be reproduced by infusion of 8-bromo-cGMP. The adenylate cyclase activator forskolin had no effect on bradykinin-induced release of t-PA and vWF, reduced PAF-induced t-PA release, but potentiated PAF-induced vWF release. These modulatory effects were only partially mimicked by infusion of 8-bromo-cAMP. None of the compounds tested was able to induce the release of t-PA or of vWF in the absence of stimulation by bradykinin or platelet-activating factor. Cyclic nucleotides can thus modulate, but not induce, the acute release of t-PA and vWF from perfused rat hindlegs.
利用离体大鼠后肢灌注系统,研究了影响环核苷酸水平的化合物对组织型纤溶酶原激活物(t-PA)和血管性血友病因子(vWF)诱导的急性释放的调节作用。血小板活化因子(PAF;5 nM)或缓激肽(0.8 microM)用于诱导t-PA和vWF的释放。鸟苷酸环化酶激活剂硝普钠和心钠素可减少t-PA和vWF的诱导释放。用NG-硝基-L-精氨酸抑制一氧化氮生成对释放无影响。硝普钠和心钠素的作用不能通过输注8-溴-cGMP重现。腺苷酸环化酶激活剂福斯高林对缓激肽诱导的t-PA和vWF释放无影响,可减少PAF诱导的t-PA释放,但增强PAF诱导的vWF释放。这些调节作用仅部分被输注8-溴-cAMP模拟。在没有缓激肽或血小板活化因子刺激的情况下,所测试的化合物均不能诱导t-PA或vWF的释放。因此,环核苷酸可调节但不能诱导灌注大鼠后肢中t-PA和vWF的急性释放。